Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer

por Morgenroth, Agnieszka, Tinkir, Ebru, Vogg, Andreas T. J., Sankaranarayanan, Ramya Ambur, Baazaoui, Fatima, Mottaghy, Felix M.
Publicado 2019

Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230

por Sankaranarayanan, Ramya Ambur, Peil, Jennifer, Vogg, Andreas T. J., Bolm, Carsten, Terhorst, Steven, Classen, Arno, Bauwens, Matthias, Maurer, Jochen, Mottaghy, Felix, Morgenroth, Agnieszka
Publicado 2023

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study

por Sankaranarayanan, Ramya Ambur, Peil, Jennifer, Vogg, Andreas T. J., Bolm, Carsten, Terhorst, Steven, Classen, Arno, Bauwens, Matthias, Maurer, Jochen, Mottaghy, Felix, Morgenroth, Agnieszka
Publicado 2022

Correction: PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer

por Sankaranarayanan, Ramya Ambur, Florea, Alexandru, Allekotte, Susanne, Vogg, Andreas T. J., Maurer, Jochen, Schäfer, Laura, Bolm, Carsten, Terhorst, Steven, Classen, Arno, Bauwens, Matthias, Morgenroth, Agnieszka, Mottaghy, Felix M.
Publicado 2023